July 17, 2023
Ophthorobotics Strengthens Patent Position For Its Lead Product IIDOphthorobotics, a preclinical-stage medtech company developing a first in class automated intravitreal injection system , announced today that it was granted a key patent for its unique drug delivery system by the european patent office (EPO).
Read full postApril 18, 2023
New Chairman of the Board appointedOphthorobotics Appoints Bernhard Günther as Chairman of the Board of Directors
Read full postApril 18, 2023
New CEO appointedOphthorobotics announced today the appointment of Miguel Serrano as CEO
Read full postApril 18, 2023
Ophthorobotics at German International Ophthalmologic Surgeons (DOC) CongressOphthorobotics will be present at the 33 German International Ophthalmologic Surgeons (DOC) Congress, which is taking place from June 17th to 19th 2021
Read full post